Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Effects of Intensive Diabetes Therapy on Neuropsychological Function in Adults in the Diabetes Control and Complications Trial

right arrow The Diabetes Control and Complications Trial Research Group*

15 February 1996 | Volume 124 Issue 4 | Pages 379-388

Objective: To examine the effect of intensive therapy on neuropsychological performance in patients who participated in the Diabetes Control and Complications Trial (DCCT).

Design: Multicenter, randomized, controlled clinical trial.

Setting: 29 DCCT clinical centers.

Patients: 1441 patients with insulin-dependent diabetes mellitus (IDDM) between 13 and 39 years of age who had had IDDM for 1 to 15 years and had no or minimal retinopathy or nephropathy at baseline. Volunteers were excluded if they had a history of substance abuse, psychological disturbance, or recurrent hypoglycemia with coma or seizure.

Intervention: Intensive therapy with 3 or more daily insulin injections or continuous subcutaneous insulin infusion, guided by 4 or more glucose tests per day, compared with conventional therapy with 1 or 2 daily insulin injections.

Outcome Measures: Neuropsychological assessments were done at baseline; years 2, 5, and 7; and the end of the study. Eight cognitive domain scores were developed from the test results and were used to identify patients whose neuropsychological performance had clinically worsened.

Results: Intensive therapy did not affect neuropsychological performance. In addition, patients who had repeated episodes of hypoglycemia did not perform differently than patients who did not have repeated episodes.

Conclusion: Intensive therapy and the attendant risk for hypoglycemia were not associated with neuropsychological impairment in the DCCT.

*A complete listing of members of the DCCT Research Group is available in Archives of Ophthalmology, 1995; 113:49-51.




This article has been cited by other articles:


Home page
Diabetes CareHome page
G. Musen, A. M. Jacobson, C. M. Ryan, P. A. Cleary, B. H. Waberski, K. Weinger, W. Dahms, M. Bayless, N. Silvers, J. Harth, et al.
Impact of Diabetes and Its Treatment on Cognitive Function Among Adolescents Who Participated in the Diabetes Control and Complications Trial
Diabetes Care, October 1, 2008; 31(10): 1933 - 1938.
[Abstract] [Full Text] [PDF]


Home page
J Pediatr PsycholHome page
J. M. Naguib, E. Kulinskaya, C. L. Lomax, and M. E. Garralda
Neuro-cognitive Performance in Children with Type 1 Diabetes--A Meta-analysis
J. Pediatr. Psychol., July 17, 2008; (2008) jsn074v1.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
The Diabetes Control and Complications Trial/Epide
Long-Term Effect of Diabetes and Its Treatment on Cognitive Function
N. Engl. J. Med., May 3, 2007; 356(18): 1842 - 1852.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Musen, I. K. Lyoo, C. R. Sparks, K. Weinger, J. Hwang, C. M. Ryan, D. C. Jimerson, J. Hennen, P. F. Renshaw, and A. M. Jacobson
Effects of Type 1 Diabetes on Gray Matter Density as Measured by Voxel-Based Morphometry
Diabetes, February 1, 2006; 55(2): 326 - 333.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. M. Wessels, S. A.R.B. Rombouts, S. Simsek, J. P.A. Kuijer, P. J. Kostense, F. Barkhof, P. Scheltens, F. J. Snoek, and R. J. Heine
Microvascular Disease in Type 1 Diabetes Alters Brain Activation: A Functional Magnetic Resonance Imaging Study
Diabetes, February 1, 2006; 55(2): 334 - 340.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. Rankins, R. M. Wellard, F. Cameron, C. McDonnell, and E. Northam
The Impact of Acute Hypoglycemia on Neuropsychological and Neurometabolite Profiles in Children With Type 1 Diabetes
Diabetes Care, November 1, 2005; 28(11): 2771 - 2773.
[Full Text] [PDF]


Home page
DiabetesHome page
A. J. Emerick, M. P. Richards, G. L. Kartje, E. J. Neafsey, and E. B. Stubbs Jr.
Experimental Diabetes Attenuates Cerebral Cortical-Evoked Forelimb Motor Responses
Diabetes, September 1, 2005; 54(9): 2764 - 2771.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. M.A. Brands, G. J. Biessels, E. H.F. de Haan, L. J. Kappelle, and R. P.C. Kessels
The Effects of Type 1 Diabetes on Cognitive Performance: A meta-analysis
Diabetes Care, March 1, 2005; 28(3): 726 - 735.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. L. Evans, R. J. McCrimmon, D. E. Flanagan, T. Keshavarz, X. Fan, E. C. McNay, R. J. Jacob, and R. S. Sherwin
Hypothalamic ATP-sensitive K + Channels Play a Key Role in Sensing Hypoglycemia and Triggering Counterregulatory Epinephrine and Glucagon Responses
Diabetes, October 1, 2004; 53(10): 2542 - 2551.
[Abstract] [Full Text] [PDF]


Home page
Clin. DiabetesHome page
E. W. Gregg and A. Brown
Cognitive and Physical Disabilities and Aging-Related Complications of Diabetes
Clin. Diabetes, July 1, 2003; 21(3): 113 - 118.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. C. Ferguson, I. J. Deary, J. C. Evans, S. Ellard, A. T. Hattersley, and B. M. Frier
Apolipoprotein-E Influences Aspects of Intellectual Ability in Type 1 Diabetes
Diabetes, January 1, 2003; 52(1): 145 - 148.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. C. Ferguson, A. Blane, P. Perros, R. J. McCrimmon, J. J.K. Best, J. Wardlaw, I. J. Deary, and B. M. Frier
Cognitive Ability and Brain Structure in Type 1 Diabetes: Relation to Microangiopathy and Preceding Severe Hypoglycemia
Diabetes, January 1, 2003; 52(1): 149 - 156.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. A. Northam, P. J. Anderson, R. Jacobs, M. Hughes, G. L Warne, and G. A. Werther
Neuropsychological Profiles of Children With Type 1 Diabetes 6 Years After Disease Onset
Diabetes Care, September 1, 2001; 24(9): 1541 - 1546.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
W. H Herman
Clinical evidence: Glycaemic control in diabetes
BMJ, July 10, 1999; 319(7202): 104 - 106.
[Full Text]


Home page
BMJHome page
T. Mandrup-Poulsen
Recent advances: Diabetes
BMJ, April 18, 1998; 316(7139): 1221 - 1225.
[Full Text]


Home page
BMJHome page
I. J Deary and B. M Frier
Severe hypoglycaemia and cognitive impairment in diabetes
BMJ, September 28, 1996; 313(7060): 767 - 768.
[Full Text]


Home page
JWatch PsychiatryHome page
Intensive Insulin for IDDM Does Not Affect Cognitive Function
Journal Watch Psychiatry, April 1, 1996; 1996(401): 18 - 18.
[Full Text]


Home page
JWatch GeneralHome page
INTENSIVE INSULIN FOR IDDM DOES NOT AFFECT COGNITIVE FUNCTION
Journal Watch (General), March 1, 1996; 1996(301): 4 - 4.
[Full Text]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1996 by the American College of Physicians.